Table 4.
Baseline characteristics | Direct estimation | Multivariate analysis | |
---|---|---|---|
Hazard ratio (95% CI) | P value | ||
Treatment group | Lansoprazole/gefarnate | 0.271 (0.146–0.504) | <0.0001 |
H. pylori status | Positive/negative | 0.986 (0.565–1.721) | 0.9616 |
CYP2C19 | PM/EM | 1.031 (0.518–2.054) | 0.9308 |
Age | 10 years’ increase | 1.189 (0.913–1.548) | 0.1987 |
Sex | Male/female | 0.978 (0.524–1.827) | 0.9455 |
Smoking status | Yes/no | 1.5 (0.815–2.758) | 0.1925 |
Alcohol consumption | Yes/no | 0.774 (0.412–1.457) | 0.4277 |
PM poor metabolizers, EM extensive metabolizers